How I Manage Treatment-Related Toxicity in Refractory Metastatic Colorectal...
ClinicalThought Discussion - Treatment decisions in the refractory setting must consider the accumulated toxicities that patients have endured during previous rounds of therapy as well as the...
View ArticleExpert Guidance in Developing Treatment Strategies for Individuals With...
Learning Module - In this CME-certified educational module, John L. Marshall, MD, reviews the latest treatment options for patients with metastatic colorectal cancer and describes his management...
View ArticleHow I Manage Patients With Chemotherapy-Refractory Metastatic CRC
ClinicalThought Discussion - As patients progress through first-line and second-line therapy, selection of therapy becomes more complicated and nuanced. Here’s how I navigate the multiple treatment...
View ArticleFocus on Metastatic Colorectal Cancer: An Interactive Decision Support Tool
Tool - This interactive treatment decision aid will let you compare your choice of therapy for patients with metastatic CRC with expert recommendations from Tanios Bekaii-Saab, MD, FACP; George A....
View ArticleMetastatic Colorectal Cancer: Areas of Consensus and Controversy Among Experts
ClinicalThought Discussion - In this commentary on the treatment of metastatic colorectal cancer, I explore areas of consensus and controversy among experts including management of...
View ArticleExpert Perspectives on Biosimilar Agents
Slideset - In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
View ArticleDownloadable Slides: Therapy Selection in Metastatic Colorectal Cancer
Slideset - In this downloadable slideset, Tanios Bekaii-Saab, MD, FACP, reviews current management strategies for patients with metastatic CRC along with key data supporting each approach.
View ArticleTherapy Selection in Metastatic Colorectal Cancer
Learning Module - In this CME/CE-certified activity, Tanios Bekaii-Saab, MD, FACP, reviews key data supporting evolving treatment choices for patients with metastatic colorectal cancer.
View ArticleSELECT-D: Dalteparin vs Rivaroxaban Anticoagulation Therapy for Patients With...
Slideset - Compared with dalteparin, rivaroxaban was associated with a lower incidence of VTE recurrence within 6 months but a higher incidence of clinically relevant bleeding events.
View ArticleHokusai VTE-Cancer Study: Edoxaban vs Dalteparin for VTE in Adult Cancer...
Slideset - Oral edoxaban was noninferior to subcutaneous dalteparin regarding combined risk of recurrent VTE or major bleeding in patients with cancer-associated VTE.
View ArticleDownloadable Slides: Expert Insight and Practical Guidance on Microsatellite...
Slideset - In this downloadable slideset, John L. Marshall, MD, Yelena Janjigian, MD, and Tim F. Greten, MD provide expert guidance on incorporating the latest data and newest therapies into the...
View ArticleQ&A From a New Mother With Metastatic Colon Cancer: My Management of the Case...
ClinicalThought Discussion - In this case study from my clinic on the treatment of a new mother with metastatic colon cancer, I explore her questions, options, therapy selection, and follow-up.
View ArticleMy Take: Integrating Biosimilars Into an Oncology Practice
ClinicalThought Discussion - Multiple biosimilars are now approved for the treatment of active cancers. Here’s what oncologists need to know.
View ArticleA “Redose” of Reality in Colorectal Cancer: Downloadable Slides
Slideset - Global CRC experts, Marc Peeters, MD, Phd, Tanios Bekaii-Saab, MD, FACP; and Axel Grothey, MD discuss new data on how to dose and sequence treatments to mitigate toxicities and optimize...
View Article“Redose” of Reality in CRC: Practical Guidance for the Care of Patients With...
Video Module - In this brief video module, Tanios Bekaii-Saab, MD, FACP; Axel Grothey, MD; and Marc Peeters, MD, PhD, discuss challenges with toxicity management and new data supporting alternative...
View ArticleInternational Perspectives in Individualizing Therapy Beyond Second-line...
Learning Module - In this case-based activity, gain evidence-based insights from international experts on therapeutic strategies for progressive metastatic colorectal cancer, from optimal sequencing of...
View ArticleInternational Perspectives in Individualizing Therapy Beyond Second-line...
Slideset - In this downloadable slideset, Tanios Bekaii-Saab, MD, FACP presents data and current strategies for managing patients with metastatic CRC in the third line of therapy and beyond with an...
View ArticleBiosimilars in the Evolving Cancer Care Landscape: Experts Address Current...
Slideset - Download these slides from a live symposium to examine the impact of biosimilar drugs on the care of patients with cancer and discuss current questions regarding the use of these agents in...
View ArticleResearch Focus: Targeting Tropomyosin Receptor Kinases in Cancer
Slideset - Download these slides on the biologic role of TRK fusions in cancer along with emerging clinical trial data on TRK-targeted therapies across multiple tumor types.
View ArticleResearch Focus: Targeting Tropomyosin Receptor Kinases in Cancer
Learning Module - In this CME-certified module with accompanying downloadable slideset, Todd M. Bauer, MD, provides expert insights on the biologic role of TRK fusions in cancer along with emerging...
View Article